KRBL Limited (KRBL) Q1 22/23 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 22/23 earnings summary
22 Oct, 2026Executive summary
Q1 FY23 standalone revenue from operations rose 21% YoY to ₹1,228.23 crore; PAT reached a quarterly record ₹164.49 crore and EPS was ₹6.99.
Consolidated PAT was ₹164.45 crore versus ₹140.76 crore YoY; auditors qualified their review over the unresolved ED investigation.
Financial highlights
Standalone total income was ₹1,239.20 crore versus ₹1,030.82 crore; PBT was ₹221.84 crore versus ₹186.42 crore YoY.
Gross profit rose to ₹403 crore from ₹325 crore; EBITDA including other income was ₹242 crore versus ₹208 crore, and cash profit was ₹183 crore versus ₹159 crore.
Domestic sales excluding energy grew 47% YoY to ₹709 crore; exports were ₹485 crore, down 4% YoY but up 73% QoQ.
Basmati sales realization rose 13% YoY and volume increased 7%.
Outlook and guidance
Domestic revenue was targeted at ₹2,500–3,000 crore for FY23, with management saying it could exceed ₹3,000 crore.
Saudi revenue was expected to increase by ₹700 crore in FY23 as the new mainstream distributor ramps up and a HoReCa/traditional-trade distributor is added.
Management expected a respectable share of Iran exports over the next three quarters through a newly established legal export channel.
Plans included expanding retail distribution and branded-rice penetration, launching regional rice and health-food products, and developing Gujarat, Karnataka and Madhya Pradesh facilities.
Latest events from KRBL Limited
- Independent review launched after director’s resignation; export receivable write-off detailed.KRBL
Investor update - Q3 revenue rose 33% and PAT nearly tripled amid crop uncertainty and an ED-related qualified review.KRBL
Q3 22/23 - Record Q2 results and surging exports, with higher procurement plans and unresolved ED matters.KRBL
Q2 22/23 - Record FY23 earnings, but Q4 margin pressure, ED uncertainty and negative operating cash flow persisted.KRBL
Q4 22/23 - Domestic growth offset export weakness as input costs pressured profits and the ED review remained qualified.KRBL
Q2 23/24 - Record Q3 revenue was export-led as the ED matter remained an audit qualification.KRBL
Q3 24/25 - Domestic growth was offset by export weakness, margin pressure and ED-related uncertainty.KRBL
Q3 23/24 - Q1 PAT rose sharply as exports surged, while ED proceedings remain an audit qualification.KRBL
Q1 25/26 - Record Q1 profitability despite export disruption; the ED matter qualified the review.KRBL
Q1 26/27